Mesoblast corporate update and financial results webcast

New york, aug. 29, 2022 (globe newswire) -- mesoblast limited (asx:msb; nasdaq:meso), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the fourth quarter and full-year ended june 30, 2022.
MESO Ratings Summary
MESO Quant Ranking